Five years of experience and observation with therapy of maintenance with very low dose thalidomide after auto-SCT in multiple myeloma

被引：0
作者：
Pezzullo, L. [1 ]
Rocco, S. [1 ]
Bene, L. [1 ]
Ferrara, M. G. [1 ]
Finizio, O. [1 ]
Nunziata, G. [1 ]
Martorelli, C. [1 ]
Mettivier, L. [1 ]
Buonanno, M. T. [1 ]
Mettivier, V [1 ]
机构：
[1] Cardarelli Hosp, Hematol Div A, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：146 / 147
页数：2
相关论文
共 50 条
  • [31] Allogeneic (Allo-SCT) Versus Autologous Stem-Cell Transplantation (Auto-SCT) after Relapse to First Line Auto-SCT in Multiple Myeloma: A Meta-Analysis with Predominantly Individual Patient Data
    Ludwig, Heinz
    Ikeda, Takashi
    Freytes, Cesar O.
    Kawamura, Koji
    Atsuta, Yoshiko
    Takamatsu, Hiroyuki
    Vesole, David H.
    Parameswaran, Hari
    Hinke, Axel
    [J]. BLOOD, 2023, 142
  • [32] Preliminary experience of the use of thalidomide maintenance therapy after autologous transplant in patients with multiple myeloma (MM).
    Castro, J
    Talavera, A
    Tejeda, C
    Cortés, L
    Fradera, J
    Vélez-García, E
    [J]. BLOOD, 2000, 96 (11) : 367B - 367B
  • [33] Donor cell leukaemia after allogeneic haematopoietic SCT followed by prolonged thalidomide maintenance for multiple myeloma
    T S Y Chan
    W-Y Au
    K Lam
    Y-F Lam
    C-C So
    A Y H Leung
    E Tse
    A K W Lie
    Y-L Kwong
    [J]. Bone Marrow Transplantation, 2012, 47 : 612 - 615
  • [34] Donor cell leukaemia after allogeneic haematopoietic SCT followed by prolonged thalidomide maintenance for multiple myeloma
    Chan, T. S. Y.
    Au, W-Y
    Lam, K.
    Lam, Y-F
    So, C-C
    Leung, A. Y. H.
    Tse, E.
    Lie, A. K. W.
    Kwong, Y-L
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 (04) : 612 - 615
  • [35] The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis
    G Cook
    G H Jackson
    G J Morgan
    N Russell
    K Kirkland
    J Lee
    R Pearce
    D I Marks
    A Pagliuca
    [J]. Bone Marrow Transplantation, 2011, 46 : 1210 - 1218
  • [36] The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis
    Cook, G.
    Jackson, G. H.
    Morgan, G. J.
    Russell, N.
    Kirkland, K.
    Lee, J.
    Pearce, R.
    Marks, D. I.
    Pagliuca, A.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 (09) : 1210 - 1218
  • [37] Maintenance therapy after thalidomide autograft improves the survival of patients with multiple myeloma
    Macro, Margareth
    [J]. HEMATOLOGIE, 2007, 13 (01): : 8 - 9
  • [38] LOW-DOSE THALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kohei, K. O.
    Ando, S.
    Hasino, S.
    Huse, H.
    Morita, R.
    Takahata, M.
    Onozawa, M.
    Kahata, K.
    Kondo, T.
    Ota, S.
    Kawamura, T.
    Kurosawa, M.
    Aikawa, K.
    Ogawa, T.
    Suzuki, S.
    Takahashi, S.
    Izumiyama, K.
    Iwasaki, H.
    Maemori, M.
    Sakai, H.
    Asaka, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 619 - 620
  • [39] Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma
    Zemanova, M.
    Scudla, V.
    Adam, Z.
    Gregora, E.
    Pour, L.
    Minarik, J.
    Pavlicek, P.
    Pika, T.
    Bacovsky, J.
    [J]. NEOPLASMA, 2008, 55 (04) : 345 - 349
  • [40] Low dose thalidomide maintenance in myeloma patients after autologous stem cell transplantation
    Bayer, R. -L.
    John, V.
    Devoe, C.
    Cannon, M.
    Klocke, J.
    Gissinger, D.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 53 - 54
12345